other material
confidence high
sentiment positive
materiality 0.60
Indivior launches $175M accelerated share repurchase with Barclays
Indivior Pharmaceuticals, Inc.
- Initial prepayment of $175M; received 3,717,473 shares from Barclays.
- Final share count based on VWAP during term; settlement by June 22, 2026.
- Part of existing $400M buyback program; $100M remains for future repurchases.
- Company reaffirms prior financial guidance; ASR reflects confidence in strategy.